Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Mucin, Sugar Cancer Vaccine Moving Into Phase I/II Trials

May 13, 1998

Therapeutic Antibodies Seeks Antivenom Product Approval

May 13, 1998

Alltracel Tumor Study Reports Positive Data

May 13, 1998

Irish Research Prize Awarded To Bug Hunter

May 13, 1998

GlycoDesign Raises C$13M For Enzyme Inhibitor Work

May 13, 1998

Brain Peptide Discovery Shows Promise For Obesity Control

May 13, 1998

Tyrphostins Attack Restenosis, Work Against Brain Cancer

May 13, 1998

Encapsulated Cell Therapy Draws US$8M For Modex

May 13, 1998

Antisoma Takes Over Company Formed With Cancer Charity

May 13, 1998

Peptide Therapeutics Signs Vaccine Deal With Pasteur

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...